The Autoimmune Protocol and Rheumatoid Arthritis: What the Research Shows

What You’ll Learn in This Article:

• Insights from in-depth interviews with long-term AIP users
• Findings from the first pilot intervention trial
• Early quantitative improvements in pain, fatigue, and sleep
• Implications for patient care, safety, and future research

Together, these studies provide the first scientific foundation for understanding how AIP may support individuals living with rheumatoid arthritis.

From Anecdote to Evidence

Long before research began, many individuals with RA turned to AIP in hopes of reducing symptoms that persisted despite medication. Across online communities and patient networks, AIP became a frequently discussed strategy for managing joint pain, inflammation, and fatigue. Reports of improved mobility, fewer flares, and better energy were common, but lacked scientific validation.

In recent years, that has begun to change. Early researchers sought to understand how patients were using AIP, what benefits and challenges they experienced, and whether AIP might offer a supportive role in RA management. The first study focused on qualitative insights, followed by the first pilot intervention trial. Although these studies do not assess biomarkers or disease activity scores in depth, they offer valuable early evidence about AIP’s feasibility, safety, and potential symptom benefits.

RA remains one of the autoimmune conditions where patients most actively explore AIP, making this early research an important first step toward understanding how dietary and lifestyle changes may complement conventional treatment.

Study 1: Qualitative Research on Patient Experience (2020)

The first published study examining AIP for RA was conducted by nutritionist and PhD candidate Julianne McNeill in New Zealand (published under Taylor, 2020). Rather than measuring inflammatory markers, the study used qualitative interviews to explore how people with RA implemented AIP, what challenges they encountered, and what benefits they perceived. [1]

Study Design

The study explored the experiences of ten adults living with rheumatoid arthritis—nine women and one man—between the ages of 28 and 60. On average, participants had been following the Autoimmune Protocol for nearly three years, with individual experience ranging from six months to five years.

Rather than focusing on laboratory markers or standardized disease scores, researchers conducted in-depth, 90-minute semi-structured interviews to better understand each participant’s personal journey with AIP. Conversations centered on what initially motivated them to try the protocol, how they implemented it in everyday life, the challenges they encountered, the forms of support that helped them continue, and the changes they perceived over time.

Importantly, the study intentionally recruited individuals who felt they had benefited from AIP. The goal was not to determine whether AIP “worked” in a clinical sense, but to explore what successful, sustained implementation looked like from the patient perspective—and to identify the factors that may support long-term adherence.

Results

Several consistent themes emerged from the interviews. Most participants were first introduced to the Autoimmune Protocol through holistic practitioners or online autoimmune communities. For many, the decision to try AIP was driven by persistent pain, limited function, and a desire for options beyond conventional treatment alone. The hope of reducing daily discomfort and regaining a sense of control over their health served as a powerful motivator.

When it came to implementation, many described choosing a deliberate start date and transitioning relatively quickly into the elimination phase—particularly those experiencing more severe symptoms. While the structure of the protocol provided clarity, participants also acknowledged meaningful challenges. The restrictive nature of the elimination phase was frequently cited as difficult, and several described navigating skepticism, misunderstanding, or dismissive attitudes from friends, family members, or even healthcare providers.

Despite these barriers, nearly all participants emphasized the importance of support. Having at least one encouraging person—a partner, friend, or knowledgeable practitioner—was often described as critical to sustaining the protocol during challenging moments.

Ultimately, pain reduction emerged as the most significant factor in maintaining AIP long term. Participants commonly reported improvements substantial enough that the dietary restrictions felt justified. For many, the perceived benefits outweighed the difficulties, reinforcing their commitment to continuing the approach.

Discussion

This qualitative study provided the first structured exploration of how individuals with rheumatoid arthritis experience the Autoimmune Protocol in real life. Rather than measuring laboratory markers or standardized disease activity scores, the research centered on patient narratives—offering valuable insight into what motivates individuals to begin AIP, what helps them sustain it, and what obstacles they encounter along the way.

Although the study was not designed to evaluate clinical efficacy, participants consistently reported meaningful improvements in pain levels, energy, sleep quality, and overall daily functioning. For many, these changes were substantial enough to influence long-term adherence, even in the face of dietary restrictions and social challenges. These patient-reported outcomes suggest that AIP may influence dimensions of health that matter deeply to individuals living with RA, including quality of life and perceived control over symptoms.

The study also highlighted the importance of preparation, social support, and access to reliable information as key facilitators of success. At the same time, it underscored common barriers—such as the restrictive nature of elimination and social skepticism—that may limit broader adoption or sustainability without guidance.

Importantly, by documenting consistent patterns across participants, this research helped move the conversation beyond anecdote. It established a foundation for future quantitative and intervention-based studies by identifying both the potential benefits worth measuring and the practical considerations necessary for real-world implementation. In this way, the findings laid important groundwork for subsequent pilot trials designed to formally assess feasibility, symptom changes, and clinical outcomes in rheumatoid arthritis. [1]

Study 2: Rheumatoid Arthritis Pilot Feasibility Study (McNeill et al., 2026)

Building on earlier qualitative research exploring patient experiences with the Autoimmune Protocol (AIP), McNeill and colleagues published the first peer-reviewed clinical study evaluating AIP in adults with rheumatoid arthritis (RA). Published in Musculoskeletal Care in 2026, this pilot feasibility study examined whether AIP could be successfully implemented in a real-world setting and whether it was associated with changes in disease activity, symptom burden, and quality of life. [2]

Study Design

This single-arm pilot study was conducted in New Zealand and enrolled adults with a confirmed diagnosis of rheumatoid arthritis. Participants completed a 4-week control phase in which they continued their usual diet, followed by an 8-week Core AIP elimination phase. Throughout the intervention, participants received nutrition education, detailed implementation resources, ongoing support from a nutrition professional, and access to a private online support community. This approach was designed to reflect how AIP is often implemented in clinical practice.

Researchers collected weekly patient-reported outcome measures using two validated rheumatoid arthritis assessment tools:

• RAPID3 (Routine Assessment of Patient Index Data 3), which evaluates disease activity
• RAID (Rheumatoid Arthritis Impact of Disease), which assesses pain, fatigue, sleep, physical function, emotional wellbeing, and overall disease impact

Additional measures included dietary adherence, food intake, body weight, waist circumference, and participant feedback regarding the feasibility of following the protocol.

The study was conducted during the COVID-19 pandemic, requiring portions of data collection and participant support to be delivered remotely. Despite these challenges, adherence remained high throughout the intervention.

Results

The study found improvements across multiple patient-reported outcomes.

Seven of the nine participants experienced meaningful improvements in rheumatoid arthritis symptoms during the AIP intervention. Four participants achieved clinically significant reductions in disease activity scores, and three participants transitioned into remission-level disease activity by the end of the study.

Researchers also observed:

• Improvements in pain
• Reductions in fatigue
• Better sleep quality
• Improved overall disease impact scores
• Reduced use of discretionary anti-inflammatory medications among many participants
• High levels of dietary adherence and participant engagement

The greatest improvements were generally observed between weeks six and eight of the intervention. Researchers also reported reductions in body weight and waist circumference among most participants, although weight loss was not an intended outcome of the study.

Discussion

This study provides the strongest clinical evidence to date supporting the use of AIP as a complementary dietary approach for rheumatoid arthritis. While the study was small and did not include a randomized control group, it demonstrated that AIP can be implemented successfully in people with RA and may be associated with improvements in disease activity, pain, fatigue, sleep, and overall quality of life.

The findings are particularly notable because fatigue and sleep disturbances remain among the most common unmet needs in rheumatoid arthritis care, even among patients receiving standard medical treatment. Researchers concluded that larger controlled trials are warranted to further evaluate the effectiveness, mechanisms, and long-term sustainability of AIP in rheumatoid arthritis management. [2]

As with all current AIP research, these findings should be viewed as preliminary. However, the publication of this peer-reviewed intervention study marks an important milestone in the growing evidence base supporting dietary and lifestyle approaches as complementary tools in autoimmune disease management.